Orbimed Advisors - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 72 filers reported holding CATALYST BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q4 2021$1,581,000
-85.8%
1,729,402
-36.2%
0.02%
-83.6%
Q3 2021$11,145,000
+21.5%
2,711,600
+28.0%
0.12%
+31.2%
Q2 2021$9,174,000
-14.1%
2,118,6000.0%0.09%
-7.0%
Q1 2021$10,678,0002,118,6000.10%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q2 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 834,449$5,265,0004.03%
ACUTA CAPITAL PARTNERS, LLC 1,357,500$8,566,0002.33%
22NW, LP 772,314$4,873,0001.74%
AIGH Capital Management LLC 421,042$2,657,0001.08%
Altium Capital Management LP 313,745$1,980,0000.74%
Worth Venture Partners, LLC 99,297$627,0000.50%
Nantahala Capital Management 1,865,334$11,770,0000.36%
Parkman Healthcare Partners LLC 189,161$1,194,0000.31%
Sio Capital Management, LLC 188,714$1,191,0000.24%
Essex Woodlands Management, Inc. 78,622$496,0000.13%
View complete list of CATALYST BIOSCIENCES INC shareholders